Renewed Momentum For Cannabis Extracts Unlocks Value in Growing Industry

FN Media Group Presents Microsmallcap.com Market Commentary

NEW YORK, Feb. 23, 2021 /PRNewswire/ -- The cannabis industry is once again gaining momentum as new jusidicitions open to CBD and North American cannabis companies find their footing. As the industry recovers after a rocky start, extracted products look primed to take the top spot in the market. In an industry flooded with cannabis biomass, value-added extraction products offer greater medical use, longer shelf lives, and easier access to emerging markets. The global medical cannabis extraction market is set to rise at a CAGR of 16.20% up to 2028. In preparation, companies like Pure Extracts (CSE:PULL) (OTCPK:PRXTF) (XFRA: A2QJAJ), Valens Company Inc. (TSX:VLNS) (OTCQX:VLNCF), MediPharm Labs Corp. (TSXV:LABS) (OTCQX:MEDIF), Neptune Wellness Solutions Inc (NASDAQ:NEPT) (TSX:NEPT), and Heritage Cannabis Holdings Corp (CSE:CANN) (OTCQX:HERTF) are establishing themselves as key extractors.

Pure Extracts Forms Key Extraction Partnerships

Pure Extracts (CSE:PULL) (OTC:PRXTF) (XFRA: A2QJAJ) is quickly building itself into one of the most recognized players in the Canadian extraction industry. The Company utilizes cutting-edge CO² and ethanol extraction and production out of its EU-GMP compliant extraction lab located just north of Whistler, British Columbia. In a highly competitive cannabis extraction market landscape, Pure Extracts has been developing key partnerships to expand its footprint throughout the Canadian market and emerging international markets.

On February 18, Pure Extracts announced that the Company had entered into a Cannabis 2.0 distribution agreement with Canada House Wellness Group to distribute Pure Extracts' line of concentrate products through Canada House's established provincial distribution channels.

"This Agreement allows us to quickly and efficiently get our outstanding line of full spectrum oil vape and edible products to retail buyers across Canada while our Sales Amendment application is being processed by Health Canada," Pure Extracts CEO, Ben Nikolaevsky, said in the Company's release.

Canada House CEO Chris Churchill-Smith commented, "We've been extremely impressed with the Pure Extracts team and the brand presence they have established, particularly in the western provinces, and are looking forward to supporting their commercialization efforts in a mutually beneficial way."

On February 16, Pure Extracts announced a licensing deal with US-based Taste-T LLC, the producer of Fireball branded cannabis-infused gummies that leverages recognizable SKUs like Margarita Chill and Fireball Cinnamon. Under the agreement, Pure Extracts will receive exclusive rights to market these products in Canada, as well as first rights to numerous other countries around the world, including Germany and the UK.

"Taste-T's gummy lineup represents a great opportunity for our Company to leverage the Fireball name, one of the few U.S. cannabis products that can legitimately be called a 'brand'. And of course, as a Canadian company, Pure Extracts is ideally suited to export this product to numerous countries around the world," CEO Nikolaevsky said of the partnership.

2021 Has Already Seen Significant Developments in the Cannabis Extracts Market

The past couple of months have seen some significant developments for major players in the cannabis extraction space. Valens Company Inc. (TSX:VLNS) (OTCQX:VLNCF) has expanded its portfolio of cannabis extract products and brands significantly so far in 2021. The company announced on February 11 the launch of its new CBD 100 high-potency CBD-dominant oil, and on January 25, Valens announced that it has acquired cannabis-infused edibles company LYF Food Technologies.

On February 17, MediPharm Labs Corp. (TSXV:LABS) (OTCQX:MEDIF) announced that it has received its Cannabis Drug Licence from Health Canada, allowing the company to manufacture and supply drugs that contain cannabis, including pharmaceutical prescription drugs containing cannabis extracts. MediPharm says that this certification significantly enhances its opportunity to work with key pharma companies to produce existing approved cannabis drugs or develop new cannabis drugs.

On January 28, Neptune Wellness Solutions Inc (NASDAQ:NEPT) (TSX:NEPT) distributed its first commercial shipment of the company's in-house developed cannabis brand Mood Ring Hashish products through the British Columbia Liquor Distribution Branch. The product will soon be available through the provincial cannabis store and private licensed retailers throughout British Columbia. The company previously began shipping its Mood Ring High CBD Oil and High CBD Capsules in December.

On January 19, Heritage Cannabis Holdings Corp (CSE:CANN) (OTCQX:HERTF) announced that the company had entered into a binding letter of intent for a three-year extraction and finished product supply agreement with Brazilian pharmaceutical distributor Entourage Participações S.A. As per the agreement, Heritage will supply Entourage with hemp-derived CBD dominant extract, cannabis-derived THC dominant extract, hemp-derived CBD softgels, and cannabis-derived THC dominant softgels for strictly pharmaceutical distribution in the Brazilian market.

As the cannabis market heats back up, the cannabis extracts market has an abundance of opportunities for leading extractors like Pure Extracts.

Click here to find out more about Pure Extracts.

DISCLAIMER: Microsmallcap.com (MSC) is the source of the Article and content set forth above.  References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. FN Media Group (FNM) is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated with MSC or any company mentioned herein. The commentary, views and opinions expressed in this release by MSC are solely those of MSC and are not shared by and do not reflect in any manner the views or opinions of FNM. Readers of this Article and content agree that they cannot and will not seek to hold liable MSC and FNM for any investment decisions by their readers or subscribers. MSC and FNM and their respective affiliated companies are a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.
 
 The Article and content related to the profiled company represent the personal and subjective views of the Author (MSC), and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author (MSC) has not independently verified or otherwise investigated all such information. None of the Author, MSC, FNM, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer's filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer's securities, including, but not limited to, the complete loss of your investment. FNM was not compensated by any public company mentioned herein to disseminate this press release but was compensated twenty five hundred dollars by MSC, a non-affiliated third party to distribute this release on behalf of Pure Extracts.
 
 FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
 
 This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MSC and FNM undertake no obligation to update such statements.

Media Contact:
FN Media Group, LLC
info@financialnews.com
+1(561)325-8757